Transcriptomic studies [61,62,63,64] comparing healthy controls and AD patient brains showed significant decreases in UBE3A levels in multiple brain regions, including the entorhinal cortex (Figure 4A), temporal lobe, and hippocampal gyrus (Figure 4B). The gene discussed is UBE3A; the disease is Alzheimer disease.